GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] we are measuring discontinuation at the wrong time and calling it noise — 41 comments in the full submission. View in context.
1k
c/tapering·submitted 12 months ago by u/arne_restrepo

[Discussion] we are measuring discontinuation at the wrong time and calling it noise

Discussionbranch of 6 comments

appetite return. That is the whole post, but I will justify it. Everything else people worry about in c/glp1eu is downstream of it. Titration speed, reflux, the endless dose arguments — most of it resolves if you sort appetite return out first, and almost nobody does. I say this having got it wrong for 21 months. My…

Read the full submission and all 41 comments →

This branch

6 comments, started 12 months ago
u/ignacio_silva125 points·12 months ago

the people who came off and restarted without shame

replysharereportpermalink
u/ismael_varga100 points·12 months ago

the people who came off and restarted without shame

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/customs_seizure_sid34 points·12 months ago·edited

interval stretching versus dose reduction

replysharereportpermalink
u/taper_off_tabitha97 points·12 months ago·edited

Strongly agree. The regain is expected.

replysharereportpermalink
u/quarter_dose_queenlow and slow54 points·12 months ago

cite the discontinuation data rather than guessing regain rates

replysharereportpermalink
u/border_paperwork69 points·12 months ago

This is correct. Discontinuation data is real.

replysharereportpermalink

← back to the whole thread

About c/tapering

Stopping on purpose: dose reduction versus interval stretching, what the discontinuation arms of STEP 1 and SURMOUNT-4 actually showed about regain, appetite return timelines, and the people who came off, regained, and went back on without treating it as a failure.

20kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/tapering rules
  1. Cite the discontinuation data rather than guessing at regain rates.
  2. No shaming people who restart.
  3. Say how long you were on and at what dose before you tapered.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.